Program
Fenfluramine
Also written as “ZX008 (Fenfluramine Hydrochloride)”, “fenfluramine hydrochloride” and “fenfluramine”.
Its studies are mostly in Epilepsies, Myoclonic · Rett Syndrome · Epilepsy, Tonic-Clonic · Lennox Gastaut Syndrome, led by UCB.
Furthest: phase 3, since Feb 5, 201611 company-led studies, 2 open or runningNext primary completion: Nov 8, 2027 (phase 3)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| UCB | 112 open or running | phase 3since Feb 5, 2016 | Feb 5, 2016 | Nov 8, 2027phase 3 · NCT05064878 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 5, 2016First study: phase 3 study in Epilepsies, MyoclonicFirst studyNCT02682927 · 262 enrolled · United States, Australia, Belgium and more
- Jun 13, 2016Phase 3 study in Epilepsies, MyoclonicNCT02823145 · 375 enrolled · United States, Australia, Belgium and more
- Aug 10, 2016Phase 3 study in Epilepsies, MyoclonicNCT02926898 · 87 enrolled · United States, Canada, France and more
- Jun 19, 2017Phase 3 study in Lennox Gastaut SyndromeNCT03355209 · 296 enrolled · United States, Australia, Belgium and more
- Sep 10, 2017Phase 3 study in Epilepsies, MyoclonicNCT03299842 · 5 enrolled · United States
- Jan 30, 2018Phase 1 study in Epilepsies, MyoclonicNCT03467113 · 9 enrolled · United States
- Apr 12, 2019Phase 3 study in Epilepsies, MyoclonicNCT03936777 · 412 enrolled · United States, Australia, Belgium and more
- Sep 22, 2021Phase 3 study in CDKL5 deficiency disorderNCT05064878 · 87 enrolled · United States, Austria, Belgium and more
- Oct 23, 2023Phase 3 study in Epilepsies, MyoclonicNCT06118255 · 25 enrolled · United States, Belgium, Germany and more
- Nov 5, 2024Phase 1 study in Healthy Study ParticipantsNCT06679413 · 22 enrolled · United States
- Mar 25, 2026Phase 3 study in Rett SyndromeNCT07503444 · 200 planned · United States, Belgium, France and more
Ahead
- Nov 8, 2027Primary completion: phase 3 study in CDKL5 deficiency disorderNCT05064878
- Feb 6, 2029Primary completion: phase 3 study in Rett SyndromeNCT07503444
TargetBeta
“Serotonin 1d (5-HT1d) receptor agonist; Serotonin 2c (5-HT2c) receptor agonist; Sigma opioid receptor antagonist”ChEMBL 37, by rule
Studies
All 11 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07503444Rett Syndrome · United States, Belgium, France and more | 3 | Recruiting | Feb 6, 2029 | 200 |
| NCT06679413Healthy Study Participants · United States | 1 | Completed | Jun 12, 2025 | 22 |
| NCT06118255Epilepsies, Myoclonic · United States, Belgium, Germany and more | 3 | Completed | Sep 1, 2026 | 25 |
| NCT05064878CDKL5 deficiency disorder · United States, Austria, Belgium and more | 3 | Active, not recruiting | Nov 8, 2027 | 87 |
| NCT03936777Epilepsies, Myoclonic · United States, Australia, Belgium and more | 3 | Completed | May 8, 2025 | 412 |
| NCT03467113Epilepsies, Myoclonic · United States | 1 | Completed | Jun 24, 2020 | 9 |
| NCT03299842Epilepsies, Myoclonic · United States | 3 | Terminated | Jul 5, 2018 | 5 |
| NCT03355209Lennox Gastaut Syndrome · United States, Australia, Belgium and more | 3 | Completed | May 23, 2024 | 296 |
| NCT02926898Epilepsies, Myoclonic · United States, Canada, France and more | 3 | Completed | Jun 5, 2018 | 87 |
| NCT02823145Epilepsies, Myoclonic · United States, Australia, Belgium and more | 3 | Completed | Jan 27, 2023 | 375 |
| NCT02682927Epilepsies, Myoclonic · United States, Australia, Belgium and more | 3 | Completed | Jul 29, 2020 | 262 |
How it is read
Names in the registry
- “ZX008 (Fenfluramine Hydrochloride)”, 5 entries
- “fenfluramine hydrochloride”, 1 entry
- “fenfluramine”, 1 entry
- “fenfluramine HCl”, 1 entry
- “Fenfluramine”, 1 entry
Conditions, from the studies’ own filings
- Epilepsies, Myoclonic, 7 studies
- Rett Syndrome, 1 study
- Epilepsy, Tonic-Clonic, 1 study
- Lennox Gastaut Syndrome, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.